GSK Dividend
Dividend criteria checks 2/6
GSK is a dividend paying company with a current yield of 4.09%. Next payment date is on 9th January, 2025 with an ex-dividend date of 14th November, 2024.
Key information
4.1%
Dividend yield
-0.04%
Buyback Yield
| Total Shareholder Yield | 4.0% |
| Future Dividend Yield | 4.8% |
| Dividend Growth | -2.1% |
| Next dividend pay date | 09 Jan 25 |
| Ex dividend date | 14 Nov 24 |
| Dividend per share | UK£0.580 |
| Payout ratio | 99% |
Recent dividend updates
GSK (LON:GSK) Is Paying Out A Dividend Of £0.15
Nov 02
GSK (LON:GSK) Is Paying Out A Dividend Of £0.15
Aug 05GSK (LON:GSK) Will Pay A Dividend Of £0.15
May 05Recent updates
GSK plc (LON:GSK) Not Flying Under The Radar
Nov 02GSK (LON:GSK) Is Paying Out A Dividend Of £0.15
Nov 02Does GSK (LON:GSK) Have A Healthy Balance Sheet?
Sep 01GSK (LON:GSK) Is Paying Out A Dividend Of £0.15
Aug 05GSK (LON:GSK) Will Pay A Dividend Of £0.15
May 05We Think Shareholders Are Less Likely To Approve A Large Pay Rise For GSK plc's (LON:GSK) CEO For Now
May 02These 4 Measures Indicate That GSK (LON:GSK) Is Using Debt Reasonably Well
Apr 19Upcoming Dividend Payment
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: GSK's dividend payments have been volatile in the past 10 years.
Growing Dividend: GSK's dividend payments have fallen over the past 10 years.
Dividend Yield vs Market
| GSK Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (GSK) | 4.1% |
| Market Bottom 25% (GB) | 2.1% |
| Market Top 25% (GB) | 5.8% |
| Industry Average (Pharmaceuticals) | 2.4% |
| Analyst forecast (GSK) (up to 3 years) | 4.8% |
Notable Dividend: GSK's dividend (4.09%) is higher than the bottom 25% of dividend payers in the UK market (2.1%).
High Dividend: GSK's dividend (4.09%) is low compared to the top 25% of dividend payers in the UK market (5.79%).
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (98.9%), GSK's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (48.1%), GSK's dividend payments are well covered by cash flows.